Our News Library | Levin Papantonio Rafferty - Personal Injury Law Firm

Our News Library

The Recalled DePuy ASR Hip - When Did DePuy and Johnson & Johnson know they were defective?

 

By Levin Papantonio Attorney Daniel Nigh

I’ve spoken with a few prospective clients who have felt bad for DePuy and Johnson & Johnson.  They thought that the corporations had good intentions with these recalled hips and just all of a sudden found out these hips were bad and immediately recalled them.  However, that couldn’t be further from the truth.  These major corporations put profit over the safety of the patients.

read more

Florida Supreme Court lets Engle progeny case jury award stand

In the first case of the so-called Engle progeny to reach the Florida Supreme Court, the court has declined to review a lower court’s decision upholding $3.3 million in compensatory damages and $25 million in punitive damages for the widow of a smoker. (R.J. Reynolds Tobacco Co. v. Martin, No. SC11-483 (Fla. July 19, 2011).)

read more

Florida Supreme Court Blocks Tobacco Appeal

By The News Service of Florida, Herald-Tribune

TALLAHASSEE

In a decision with huge implications for lawsuits against tobacco companies, the Florida Supreme Court on Tuesday declined to hear R.J. Reynolds’ appeal of a $28.3 million verdict in the death of a Panhandle smoker.

read more

LP Client Obtains $8 Million Jury Verdict in Fosamax Injury Case

[New York, N.Y., June 25, 2010] A jury in the United States District Court for the Southern District of New York found that Merck's osteoporosis drug Fosamax was defectively designed and unreasonably dangerous. As reported in the Wall St. Journal, the jury verdict raises serious questions about the safety of Fosamax for some patients. A medication widely prescribed for loss of bone density which might lead to osteoporosis, Fosamax has been linked not only to osteonecrosis of the jaw (a rotting of the jaw bone), but also more recently to serious fractures of the femur.

read more

Rezulin Plaintiff Lands $2 Million Verdict

Release Date: 4/26/2004

Case Turns On What Constitutes Adequate Warning

By Correy E. Stephenson

In the latest Rezulin case to reach trial, a New York jury awarded $2 million to a woman who suffered side effects from the diabetes drug, but had no evidence of permanent liver damage.

With approximately 8,700 Rezulin lawsuits filed in state and federal courts across the country, the April trial was closely watched for indications of whether the mass tort is likely to be successful.

read more

Conoco to pay $70 million

Source: Pensacola News Journal | Release Date: 4/6/2004

Settlement covers property, medical study in Agrico toxic case

Steve Mraz @ PensacolaNewsJournal.com

ConocoPhillips has agreed to a $70 million settlement with Pensacola residents whose property is potentially contaminated by a toxic plume that has spread from the old Agrico Chemical Co. fertilizer plant in central Pensacola to Bayou Texar.

read more

Pages